The anti-HIV-1 activity associated with saliva (Q34738486)

4 August 2017

1 reference

title

The anti-HIV-1 activity associated with saliva (English)

1 reference

4 August 2017

1 reference

N Shine

1

1 reference

4 August 2017

K Konopka

series ordinal

2

1 reference

4 August 2017

N Düzgüneş

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Journal of Dental Research

4 August 2017

1 reference

4 August 2017

76

1 reference

4 August 2017

634-640

1 reference

4 August 2017

2

1 reference

In vitro inhibition of HIV-1 infectivity by human salivas

4 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Managing anxiety and pain during dental treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Heparin-induced conformational change and activation of mucus proteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Saliva inhibits HIV-1 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Tissue distribution of antileukoprotease and lysozyme in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Components of saliva inactivate human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Tryptase TL2in the membrane of human T4+lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Low occupational risk of human immunodeficiency virus infection among dental professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Human Submandibular Saliva Aggregates HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

The beta-chemokines, HIV type 1 second receptors, and exposed uninfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Epidermal and mucosal dendritic cells and HIV1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HIV infection and the dentist. 1. The presence of HIV in saliva and its implications to dental practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

HIV infection and the dentist. 2. The diagnosis and management of gingivitis and periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00220345970760020301

10.1177/00220345970760020301

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference